| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 697653 | Null | 3.6295237294955e-006 | 0.35772694 |
| NSC 382035 | 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- | 3.88440367201721e-005 | 0.86387956 |
| NSC 753221 | 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline | 4.18332145614864e-005 | 0.55593166 |
| NSC 615441 | 1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride | 4.88335076207314e-005 | 0.63608314 |
| NSC 710204 | Null | 4.88335076207314e-005 | 0.45677431 |
| NSC 740 | Methotrexate | 4.93279880911877e-006 | 0.93801699 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 6.70485325419773e-005 | 0.84616877 |
| NSC 694485 | Benzoic acid, 4-[[(2,4-diaminopteridinyl)-6-methyl] (formyl)amino]- | 6.70485325419777e-005 | 0.5776866 |
| NSC 696921 | Null | 6.70485325419777e-005 | 0.22234715 |
| NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 6.70485325419777e-005 | 0.40812165 |